Correlation Between Cementos Pacasmayo and Abcellera Biologics
Can any of the company-specific risk be diversified away by investing in both Cementos Pacasmayo and Abcellera Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cementos Pacasmayo and Abcellera Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cementos Pacasmayo SAA and Abcellera Biologics, you can compare the effects of market volatilities on Cementos Pacasmayo and Abcellera Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cementos Pacasmayo with a short position of Abcellera Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cementos Pacasmayo and Abcellera Biologics.
Diversification Opportunities for Cementos Pacasmayo and Abcellera Biologics
0.43 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Cementos and Abcellera is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding Cementos Pacasmayo SAA and Abcellera Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abcellera Biologics and Cementos Pacasmayo is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cementos Pacasmayo SAA are associated (or correlated) with Abcellera Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abcellera Biologics has no effect on the direction of Cementos Pacasmayo i.e., Cementos Pacasmayo and Abcellera Biologics go up and down completely randomly.
Pair Corralation between Cementos Pacasmayo and Abcellera Biologics
Given the investment horizon of 90 days Cementos Pacasmayo SAA is expected to generate 0.48 times more return on investment than Abcellera Biologics. However, Cementos Pacasmayo SAA is 2.07 times less risky than Abcellera Biologics. It trades about 0.03 of its potential returns per unit of risk. Abcellera Biologics is currently generating about -0.05 per unit of risk. If you would invest 486.00 in Cementos Pacasmayo SAA on September 3, 2024 and sell it today you would earn a total of 89.00 from holding Cementos Pacasmayo SAA or generate 18.31% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cementos Pacasmayo SAA vs. Abcellera Biologics
Performance |
| Timeline |
| Cementos Pacasmayo SAA |
| Abcellera Biologics |
Cementos Pacasmayo and Abcellera Biologics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cementos Pacasmayo and Abcellera Biologics
The main advantage of trading using opposite Cementos Pacasmayo and Abcellera Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cementos Pacasmayo position performs unexpectedly, Abcellera Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abcellera Biologics will offset losses from the drop in Abcellera Biologics' long position.| Cementos Pacasmayo vs. Summit Materials | Cementos Pacasmayo vs. Eagle Materials | Cementos Pacasmayo vs. United States Lime | Cementos Pacasmayo vs. James Hardie Industries |
| Abcellera Biologics vs. Hepion Pharmaceuticals | Abcellera Biologics vs. Krystal Biotech | Abcellera Biologics vs. CureVac NV | Abcellera Biologics vs. Vir Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |